Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Gross Margin (2022 - 2026)

Cannabis Bioscience International Holdings' Gross Margin history spans 5 years, with the latest figure at 72.82% for Q1 2026.

  • On a quarterly basis, Gross Margin rose 10273.0% to 72.82% in Q1 2026 year-over-year; TTM through Feb 2026 was 78.78%, a 801.0% decrease, with the full-year FY2025 number at 86.76%, up 509.0% from a year prior.
  • Gross Margin hit 72.82% in Q1 2026 for Cannabis Bioscience International Holdings, down from 80.29% in the prior quarter.
  • Over the last five years, Gross Margin for CBIH hit a ceiling of 95.33% in Q3 2024 and a floor of 29.9% in Q1 2025.
  • Historically, Gross Margin has averaged 70.71% across 5 years, with a median of 78.31% in 2023.
  • Biggest five-year swings in Gross Margin: plummeted -9747bps in 2025 and later skyrocketed 10273bps in 2026.
  • Tracing CBIH's Gross Margin over 5 years: stood at 91.41% in 2022, then fell by -17bps to 76.33% in 2023, then rose by 17bps to 89.49% in 2024, then decreased by -10bps to 80.29% in 2025, then decreased by -9bps to 72.82% in 2026.
  • Business Quant data shows Gross Margin for CBIH at 72.82% in Q1 2026, 80.29% in Q4 2025, and 66.35% in Q3 2025.